LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 57.18 | 84.90 | 5513 | 6963 | 0.7917 | 0.9279 | MN20160318_Q02 | F06 |
MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 57.18 | 84.90 | 6683 | 6963 | 0.9597 | 0.9871 | MN20160318_Q02 | F06 |
MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 58.88 | 84.90 | 6669 | 7291 | 0.9146 | 0.9724 | MN20160318_Q02 | E03 |
MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 58.88 | 84.90 | 6858 | 7291 | 0.9405 | 0.9810 | MN20160318_Q02 | E03 |
MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 58.88 | 84.90 | 5368 | 7291 | 0.7362 | 0.9069 | MN20160318_Q02 | F06 |
MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 58.88 | 84.90 | 6923 | 7291 | 0.9494 | 0.9839 | MN20160318_Q02 | F06 |
MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 60.59 | 84.90 | 6931 | 7641 | 0.9070 | 0.9701 | MN20160318_Q02 | E03 |
MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 60.59 | 84.90 | 7156 | 7641 | 0.9364 | 0.9799 | MN20160318_Q02 | E03 |
MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 60.59 | 84.90 | 5053 | 7641 | 0.6612 | 0.8765 | MN20160318_Q02 | F06 |
MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 60.59 | 84.90 | 7163 | 7641 | 0.9373 | 0.9802 | MN20160318_Q02 | F06 |
MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 62.29 | 84.90 | 7239 | 7934 | 0.9123 | 0.9722 | MN20160318_Q02 | E03 |
MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 62.29 | 84.90 | 7506 | 7934 | 0.9460 | 0.9831 | MN20160318_Q02 | E03 |
MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 62.29 | 84.90 | 4705 | 7934 | 0.5930 | 0.8466 | MN20160318_Q02 | F06 |
MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 62.29 | 84.90 | 7402 | 7934 | 0.9329 | 0.9789 | MN20160318_Q02 | F06 |
MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 63.99 | 84.90 | 7469 | 8212 | 0.9095 | 0.9714 | MN20160318_Q02 | E03 |
MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 63.99 | 84.90 | 7753 | 8212 | 0.9441 | 0.9826 | MN20160318_Q02 | E03 |
MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 63.99 | 84.90 | 4504 | 8212 | 0.5484 | 0.8259 | MN20160318_Q02 | F06 |
MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 63.99 | 84.90 | 7662 | 8212 | 0.9330 | 0.9791 | MN20160318_Q02 | F06 |
MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 65.70 | 84.90 | 7454 | 8484 | 0.8786 | 0.9614 | MN20160318_Q02 | E03 |
MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 65.70 | 84.90 | 8027 | 8484 | 0.9461 | 0.9834 | MN20160318_Q02 | E03 |
MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 65.70 | 84.90 | 4244 | 8484 | 0.5002 | 0.8020 | MN20160318_Q02 | F06 |
MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 65.70 | 84.90 | 7913 | 8484 | 0.9327 | 0.9791 | MN20160318_Q02 | F06 |
MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 67.41 | 84.90 | 7505 | 8766 | 0.8561 | 0.9541 | MN20160318_Q02 | E03 |
MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 67.41 | 84.90 | 8282 | 8766 | 0.9448 | 0.9831 | MN20160318_Q02 | E03 |
MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 67.41 | 84.90 | 4108 | 8766 | 0.4686 | 0.7858 | MN20160318_Q02 | F06 |